Transversus Abdominis and Transversalis Fascia Plane Block Combination for Cesarean Section (TAPTFPB)

Ataturk University

Status: Completed

Conditions: Ceserean Section and Postoperative Pain

Treatments: Procedure: Intrathecal Morphine; Procedure: Transversalis fascia plane block and transversus abdominis plane block

Study type: Interventional

Funder types: Other

Identifiers

NCT06944912

AUTFTAPTFP

Details and patient eligibility

About

Cesarean delivery rates are rising globally, and effective postoperative analgesia is crucial for maternal recovery and newborn care. While intrathecal morphine offers strong analgesia, it may cause side effects such as nausea, pruritus, or respiratory depression. The transversus abdominis plane (TAP) block provides somatic pain relief but is often insufficient alone. The transversalis fascia plane block (TFPB) has been shown to enhance lower abdominal analgesia. This study aims to evaluate whether combining TAP and TFP blocks can provide analgesic efficacy comparable to intrathecal morphine in cesarean section patients who are unable to receive opioids or are at high risk of side effects.

Enrollment: 100 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18-45 years old
• American Society of Anesthesiologists physical score I or II
• caesarean section with a Pfannenstiel incision

Exclusion criteria

• additional surgical intervention, or received general anaesthesia,
• hypersensitivity to the agents to be used
• BMI greater than 35 kg m-2
• coagulopathy,
• local infection,
• opioid addiction,
• pregnancy-related hypertension
• diabetes mellitus

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

100 participants in 2 patient groups

Transversalis fascia+Transversus abominis plane block

Active Comparator group

Treatment:

Procedure: Transversalis fascia plane block and transversus abdominis plane block

Intrathecal Morphine

Active Comparator group

Treatment:

Procedure: Intrathecal Morphine